<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39212385</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2C.</ArticleTitle><Pagination><StartPage>e0133524</StartPage><MedlinePgn>e0133524</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01335-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01335-24</ELocationID><Abstract><AbstractText Label="UNLABELLED">Ubiquitin modification of viral proteins to degrade or regulate their function is one of the strategies of the host to resist viral infection. Here, we report that ubiquitin protein ligase E3C (UBE3C), an E3 ubiquitin ligase, displayed inhibitory effects on EV-A71 replication. UBE3C knockdown resulted in increased viral protein levels and virus titers, whereas overexpression of UBE3C reduced EV-A71 replication. To explore the mechanism by which UBE3C affected EV-A71 infection, we found that the C-terminal of UBE3C bound to 2C protein and facilitated K33/K48-linked ubiquitination degradation of 2C K268. Moreover, UBE3C lost its ability to degrade 2C K268R and had a diminished inhibitory impact against the replication of recombinant EV-A71-FY-2C K268R. In addition, UBE3C also promoted ubiquitination degradation of the 2C protein of CVB3 and CVA16 and inhibited viral replication. Thus, our findings reveal a novel mechanism that UBE3C acts as an enterovirus host restriction factor, including EV-A71, by targeting the 2C protein.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">The highly conserved 2C protein of EV-A71 is a multifunctional protein and plays a key role in the replication cycle. In this study, we demonstrated for the first time that UBE3C promoted the degradation of 2C K268 <i>via</i> K33/K48-linked ubiquitination, thereby inhibiting viral proliferation. Our findings advance the knowledge related to the roles of 2C in EV-A71 virulence and the ubiquitination pathway in the host restriction of EV-A71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Boming</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ge</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqiang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5956-077X</Identifier><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3725-3258</Identifier><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021-I2M-1-030</GrantID><Agency>CAMS Innovation Fund for Medicinal Sciences</Agency><Country /></Grant><Grant><GrantID>82394464 (82394460)</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.26</RegistryNumber><NameOfSubstance UI="C555759">UBE3C protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="Y">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2C</Keyword><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">UBE3C</Keyword><Keyword MajorTopicYN="N">ubiquitination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>30</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39212385</ArticleId><ArticleId IdType="pmc">PMC11494953</ArticleId><ArticleId IdType="doi">10.1128/jvi.01335-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J, Thibaut HJ, Strating J, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368–381. doi:10.1038/s41579-018-0005-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Tian J, Qin B, Wojdyla JA, Wang B, Zhao Z, Wang M, Cui S. 2017. Crystal structure of 2C helicase from enterovirus 71. Sci Adv 3:e1602573. doi:10.1126/sciadv.1602573</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1602573</ArticleId><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Li YH. 2019. Recent progress on functional genomics research of enterovirus 71. Virol Sin 34:9–21. doi:10.1007/s12250-018-0071-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, Wang C, Wang C, Yang R, Bai P, Zhang XY, Kong J, Yin L, Qiu Y, Zhou X. 2021. Antiviral peptides targeting the helicase activity of enterovirus nonstructural protein 2C. J Virol 95:e02324-20. doi:10.1128/JVI.02324-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02324-20</ArticleId><ArticleId IdType="pmc">PMC8315976</ArticleId><ArticleId IdType="pubmed">33789997</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin C, Zhao H, Xia X, Pan Z, Li D, Zhang L. 2024. Picornavirus 2C proteins: structure-function relationships and interactions with host factors. Front Cell Infect Microbiol 14:1347615. doi:10.3389/fcimb.2024.1347615</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2024.1347615</ArticleId><ArticleId IdType="pmc">PMC10921941</ArticleId><ArticleId IdType="pubmed">38465233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67:425–479. doi:10.1146/annurev.biochem.67.1.425</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.67.1.425</ArticleId><ArticleId IdType="pubmed">9759494</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Ye Y. 2008. Polyubiquitin chains: functions, structures, and mechanisms. Cell Mol Life Sci 65:2397–2406. doi:10.1007/s00018-008-8090-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-008-8090-6</ArticleId><ArticleId IdType="pmc">PMC2700825</ArticleId><ArticleId IdType="pubmed">18438605</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracz M, Bialek W. 2021. Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett 26:1. doi:10.1186/s11658-020-00245-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-020-00245-6</ArticleId><ArticleId IdType="pmc">PMC7786512</ArticleId><ArticleId IdType="pubmed">33402098</ArticleId></ArticleIdList></Reference><Reference><Citation>Swatek KN, Usher JL, Kueck AF, Gladkova C, Mevissen TET, Pruneda JN, Skern T, Komander D. 2019. Insights into ubiquitin chain architecture using Ub-clipping. Nature New Biol 572:533–537. doi:10.1038/s41586-019-1482-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1482-y</ArticleId><ArticleId IdType="pmc">PMC6823057</ArticleId><ArticleId IdType="pubmed">31413367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YH, Huang TY, Lin YT, Lin SY, Li WH, Hsiao HJ, Yan RL, Tang HW, Shen ZQ, Chen GC, Wu KP, Tsai TF, Chen RH. 2021. VPS34 K29/K48 branched ubiquitination governed by UBE3C and TRABID regulates autophagy, proteostasis and liver metabolism. Nat Commun 12:1322. doi:10.1038/s41467-021-21715-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21715-1</ArticleId><ArticleId IdType="pmc">PMC7910580</ArticleId><ArticleId IdType="pubmed">33637724</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Li R, Ahmad I, Liu X, Johnson SF, Sun L, Zheng YH. 2022. Cul3-KLHL20 E3 ubiquitin ligase plays a key role in the arms race between HIV-1 Nef and host SERINC5 restriction. Nat Commun 13:2242. doi:10.1038/s41467-022-30026-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30026-y</ArticleId><ArticleId IdType="pmc">PMC9042822</ArticleId><ArticleId IdType="pubmed">35474067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Zhong M, Cui BM, Yan HY, Wu S, Wang K, Li YH. 2022. Neddylation of enterovirus 71 VP2 protein reduces its stability and restricts viral replication. J Virol 96:e0059822. doi:10.1128/jvi.00598-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00598-22</ArticleId><ArticleId IdType="pmc">PMC9131864</ArticleId><ArticleId IdType="pubmed">35510863</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang L, Yang X, Chen Y, Huang F, Yuan Y, Chen X, Zuo Y, Miao Y, Gu J, Guo H, Xia W, Peng Y, Tang M, Huang Z, Wang Y, Ma J, Jiang J, Zhou W, Zheng H, Shi W. 2023. Ubiquitin E3 ligase SPOP is a host negative regulator of enterovirus 71-encoded 2A protease. J Virol 97:e0078623. doi:10.1128/jvi.00786-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00786-23</ArticleId><ArticleId IdType="pmc">PMC10617436</ArticleId><ArticleId IdType="pubmed">37796126</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan S-J, Zhan S-K, Ji W-Z, Pan Y-X, Liu W, Li D-Y, Huang P, Zhang X-X, Cao C-Y, Zhang J, Bian L-G, Sun B, Sun Q-F. 2015. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7. Sci Rep 5:11066. doi:10.1038/srep11066</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11066</ArticleId><ArticleId IdType="pmc">PMC4464076</ArticleId><ArticleId IdType="pubmed">26067607</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel MA, Elliott PR, Swatek KN, Simicek M, Pruneda JN, Wagstaff JL, Freund SMV, Komander D. 2015. Assembly and specific recognition of K29- and K33-linked polyubiquitin. Mol Cell 58:95–109. doi:10.1016/j.molcel.2015.01.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.01.042</ArticleId><ArticleId IdType="pmc">PMC4386031</ArticleId><ArticleId IdType="pubmed">25752577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CL, Goldberg AL. 2017. Ubiquitinated proteins promote the association of proteasomes with the deubiquitinating enzyme Usp14 and the ubiquitin ligase Ube3c. Proc Natl Acad Sci U S A 114:E3404–E3413. doi:10.1073/pnas.1701734114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1701734114</ArticleId><ArticleId IdType="pmc">PMC5410784</ArticleId><ArticleId IdType="pubmed">28396413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Chen Y, Gu Q, Fu Y, Wang Y, Liu C, Xie H, Liao Y, Zheng Z, Liu P, Li M. 2024. UBE3C tunes autophagy via ATG4B ubiquitination. Autophagy 20:645–658. doi:10.1080/15548627.2023.2299514</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2023.2299514</ArticleId><ArticleId IdType="pmc">PMC10936621</ArticleId><ArticleId IdType="pubmed">38146933</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Hayward GS. 2010. The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33:863–877. doi:10.1016/j.immuni.2010.11.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.11.027</ArticleId><ArticleId IdType="pmc">PMC3012379</ArticleId><ArticleId IdType="pubmed">21167755</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Jian X, Yin P, Zhu G, Zhang L. 2019. Elucidating the host interactome of EV-A71 2C reveals viral dependency factors. Front Microbiol 10:636. doi:10.3389/fmicb.2019.00636</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00636</ArticleId><ArticleId IdType="pmc">PMC6454016</ArticleId><ArticleId IdType="pubmed">31001221</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Sivaraman J. 2020. Crystal structure of HECT domain of UBE3C E3 ligase and its ubiquitination activity. Biochem J 477:905–923. doi:10.1042/BCJ20200027</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20200027</ArticleId><ArticleId IdType="pubmed">32039437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Mehta D, Mishra N, Nayak D, Sunil S. 2020. Role of host-mediated post-translational modifications (PTMs) in RNA virus pathogenesis. Int J Mol Sci 22:323. doi:10.3390/ijms22010323</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010323</ArticleId><ArticleId IdType="pmc">PMC7796338</ArticleId><ArticleId IdType="pubmed">33396899</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A, Wang W, Wang Y, Chen K, Xiao F, Hu D, Hui L, Liu W, Feng Y, Li G, Tan Q, Liu Y, Wu K, Wu J. 2020. NS5 conservative site is required for Zika virus to restrict the RIG-I signaling. Front Immunol 11:51. doi:10.3389/fimmu.2020.00051</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00051</ArticleId><ArticleId IdType="pmc">PMC7033454</ArticleId><ArticleId IdType="pubmed">32117232</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-C, Chang L-Y, Wang Y-W, Chen Y-C, Weng K-F, Shih S-R, Shih H-M. 2011. Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. J Biol Chem 286:31373–31384. doi:10.1074/jbc.M111.254896</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.254896</ArticleId><ArticleId IdType="pmc">PMC3173077</ArticleId><ArticleId IdType="pubmed">21784861</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao H, Hao S, Chen H, Chen Z, Zhang Y, Wang J, Wang H, Zhang B, Qiu J, Deng F, Guan W. 2019. N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication. Nucleic Acids Res 47:362–374. doi:10.1093/nar/gky1007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1007</ArticleId><ArticleId IdType="pmc">PMC6326802</ArticleId><ArticleId IdType="pubmed">30364964</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahnefeld A, Klingel K, Schuermann A, Diny NL, Althof N, Lindner A, Bleienheuft P, Savvatis K, Respondek D, Opitz E, Ketscher L, Sauter M, Seifert U, Tschöpe C, Poller W, Knobeloch KP, Voigt A. 2014. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Circulation 130:1589–1600. doi:10.1161/CIRCULATIONAHA.114.009847</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.009847</ArticleId><ArticleId IdType="pubmed">25165091</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Tian J, Zhang C, Qin B, Cui S. 2018. Crystal structure of a soluble fragment of poliovirus 2CATPase. PLoS Pathog 14:e1007304. doi:10.1371/journal.ppat.1007304</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007304</ArticleId><ArticleId IdType="pmc">PMC6166989</ArticleId><ArticleId IdType="pubmed">30231078</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Mar KB, Sari L, Gaszek IK, Cheng Q, Evers BM, Shelton JM, Wight-Carter M, Siegwart DJ, Lin MM, Schoggins JW. 2021. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell 184:3410–3425. doi:10.1016/j.cell.2021.04.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.047</ArticleId><ArticleId IdType="pmc">PMC8276836</ArticleId><ArticleId IdType="pubmed">34062120</ArticleId></ArticleIdList></Reference><Reference><Citation>He B, Liang J, Qin Q, Zhang Y, Shi S, Cao J, Zhang Z, Bie Q, Zhao R, Wei L, Zhang B, Zhang B. 2024. IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53. Genes Dis 11:495–508. doi:10.1016/j.gendis.2023.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2023.01.027</ArticleId><ArticleId IdType="pmc">PMC10425805</ArticleId><ArticleId IdType="pubmed">37588218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Zhang L. 2022. Structure prediction and potential inhibitors docking of enterovirus 2C proteins. Front Microbiol 13:856574. doi:10.3389/fmicb.2022.856574</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.856574</ArticleId><ArticleId IdType="pmc">PMC9100428</ArticleId><ArticleId IdType="pubmed">35572704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Li K, Cui BM, Yan HY, Wu S, Wang K, Yang G, Jiang JD, Li YH. 2024. Tribbles pseudokinase 3 promotes enterovirus A71 infection via dual mechanisms. Emerg Microbes Infect 13:2307514. doi:10.1080/22221751.2024.2307514</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2024.2307514</ArticleId><ArticleId IdType="pmc">PMC10829831</ArticleId><ArticleId IdType="pubmed">38240287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Cui BM, Yan HY, Wu S, Wang K, Yang G, Jiang JD, Li YH. 2023. Targeting 7-dehydrocholesterol reductase against EV-A71 replication by upregulating interferon response. Antiviral Res 209:105497. doi:10.1016/j.antiviral.2022.105497</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105497</ArticleId><ArticleId IdType="pubmed">36528172</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Epidemiol 27:493–497. doi:10.1093/oxfordjournals.aje.a118408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>